Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells

Rat pancreatic α- and β-cells are critically dependent on hormonal signals generating cyclic AMP (cAMP) as a synergistic messenger for nutrient-induced hormone release. Several peptides of the glucagon-secretin family have been proposed as physiological ligands for cAMP production in β-cells, but their relative importance for islet function is still unknown. The present study shows expression at the RNA level in β-cells of receptors for glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide I(7-36) amide (GLP-I), while RNA from islet α-cells hybridized only with GIP receptor cDNA. Western blots confirmed that GLP-I receptors were expressed in β-cells and not in α-cells. Receptor activity, measured as cellular cAMP production after exposing islet β-cells for 15 min to a range of peptide concentrations, was already detected using 10 pmol/l GLP-I and 50 pmol/l GIP but required 1 nmol/l glucagon. EC50 values of GLP-I- and GIP-induced cAMP formation were comparable (0.2 nmol/l) and 45-fold lower than the EC50 of glucagon (9 nmol/l). Maximal stimulation of cAMP production was comparable for the three peptides. In purified α-cells, 1 nmol/l GLP-I failed to increase cAMP levels, while 10 pmol/l to 10 nmol/l GIP exerted similar stimulatory effects as in β-cells. In conclusion, these data show that stimulation of glucagon, GLP-I, and GIP receptors in rat β-cells causes cAMP production required for insulin release, while adenylate cyclase in α-cells is positively regulated by GIP.

[1]  B. Thorens,et al.  Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas. , 1995, The Biochemical journal.

[2]  E. Nishimura,et al.  Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids. , 1995, Endocrinology.

[3]  B. Göke,et al.  Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide , 1995, Diabetes.

[4]  M. Brownstein,et al.  Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. , 1993, Endocrinology.

[5]  J. Holst,et al.  The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha- and beta-cell tumor phenotypes. , 1993, Endocrinology.

[6]  D. Pipeleers,et al.  Heterogeneity in glucose sensitivity among pancreatic beta‐cells is correlated to differences in glucose phosphorylation rather than glucose transport. , 1993, The EMBO journal.

[7]  P. Brubaker,et al.  Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. , 1993, Endocrinology.

[8]  F J Grant,et al.  Expression cloning and signaling properties of the rat glucagon receptor. , 1993, Science.

[9]  J. Habener,et al.  Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37) , 1993, Nature.

[10]  S. Godtfredsen,et al.  Beta-cells do not have glucagon receptors but GLP-1 receptors ! , 1993 .

[11]  B. Thorens.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Frans,et al.  Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. , 1992, The Journal of clinical investigation.

[13]  J. Habener,et al.  Functional receptors for the insulinotropic hormone glucagon‐like peptide‐I(7–37) on a somatostatin secreting cell line , 1991, FEBS letters.

[14]  S. Ohashi,et al.  Reduced Insulinotropic Effects of Glucagonlike Peptide I-(7–36)-Amide and Gastric Inhibitory Polypeptide in Isolated Perfused Diabetic Rat Pancreas , 1990, Diabetes.

[15]  B. Göke,et al.  Synergistic stimulatory effect of glucagon‐like peptide‐1 (7–36) amide and glucose‐dependent insulin‐releasing polypeptide on the endocrine rat pancreas , 1989, FEBS letters.

[16]  G. Weir,et al.  Glucagonlike Peptide I (7–37) Actions on Endocrine Pancreas , 1989, Diabetes.

[17]  F M Matschinsky,et al.  Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. , 1987, Physiological reviews.

[18]  D. Pipeleers,et al.  Differences in adrenergic recognition by pancreatic A and B cells. , 1986, Science.

[19]  D. Pipeleers,et al.  A new in vitro model for the study of pancreatic A and B cells. , 1985, Endocrinology.

[20]  V. Rogiers,et al.  Pancreatic hormone receptors on islet cells. , 1985, Endocrinology.

[21]  D. Pipeleers,et al.  Regulation of adenosine 3',5'-monophosphate levels in the pancreatic B cell. , 1985, Endocrinology.

[22]  E. Hooghe-Peters,et al.  Interplay of nutrients and hormones in the regulation of insulin release. , 1985, Endocrinology.

[23]  D. Pipeleers,et al.  Interplay of nutrients and hormones in the regulation of glucagon release. , 1985, Endocrinology.

[24]  L. Orci,et al.  New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat , 1982, Diabetes.

[25]  J. Brown,et al.  Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas. , 1978, Endocrinology.